Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01652885 · ClinicalTrials.gov registry record · Phase 1
Safety, Tolerability, and PK of AN2728 in Adolescents With Atopic Dermatitis
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 23
- Enrollment target
NCT01652885 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 23 participants.
The verdict
NCT01652885, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 23 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the safety, tolerability, and systemic exposure of AN2728 Topical Ointment, 2%, in subjects with atopic dermatitis.
Interventions
- DRUG AN2728 Topical Ointment, 2%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2012-07 |
| Est. Completion | 2012-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01652885
The ClinicalTrials.gov registry entry for NCT01652885 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AN2728 Topical Ointment, 2% is the first listed.
NCT01652885 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01652885 about?
NCT01652885 is a clinical study titled "Safety, Tolerability, and PK of AN2728 in Adolescents With Atopic Dermatitis". The purpose of this study is to investigate the safety, tolerability, and systemic exposure of AN2728 Topical Ointment, 2%, in subjects with atopic dermatitis.
What is the current status of trial NCT01652885?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 23 participants. The study started on 2012-07. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01652885?
The interventions under investigation include: AN2728 Topical Ointment, 2% (DRUG).
Who is sponsoring clinical trial NCT01652885?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.